Literature DB >> 31452394

Concept and Implementation of a Novel Patch Pump for Insulin Delivery.

Sina Ulbrich1, Delia Waldenmaier1, Cornelia Haug1, Guido Freckmann1, Til Rendschmidt2, Thomas Künsting2.   

Abstract

With the motivation to provide a small and discreet patch pump that complies with several customer needs, the recently CE-marked Accu-Chek® Solo micropump system was designed. The system consists of a tubeless insulin pump wirelessly controlled by the so-called diabetes manager. Via diabetes manager, basal rates and boluses are programmed; an integrated blood glucose meter and bolus calculator supports users in bolusing and offers several diary functions. The micropump features a quick bolus button for bolus initiation directly on the pump and is complemented by a disposable reservoir holding up to 200 U of rapid-acting insulin. The assembled pump is attached to the body via a pump holder containing soft cannula. The modular principle enables independent replacement of the single components if necessary.

Entities:  

Keywords:  CSII; insulin pump; patch pump; technical features

Mesh:

Substances:

Year:  2019        PMID: 31452394      PMCID: PMC7196855          DOI: 10.1177/1932296819871626

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  13 in total

Review 1.  Continuous subcutaneous insulin infusion: Special needs for children.

Authors:  Peter Adolfsson; Ralph Ziegler; Ragnar Hanas
Journal:  Pediatr Diabetes       Date:  2017-04-20       Impact factor: 4.866

2.  Patch Pumps: Are They All the Same?

Authors:  Lutz Heinemann; Delia Waldenmaier; Bernd Kulzer; Ralph Ziegler; Barry Ginsberg; Guido Freckmann
Journal:  J Diabetes Sci Technol       Date:  2018-08-22

3.  Durability of insulin pump use in pediatric patients with type 1 diabetes.

Authors:  Jamie R Wood; Elaine C Moreland; Lisa K Volkening; Britta M Svoren; Deborah A Butler; Lori M B Laffel
Journal:  Diabetes Care       Date:  2006-11       Impact factor: 19.112

4.  Patient Perceptions and Preferences for a Mealtime Insulin Delivery Patch.

Authors:  Mark Peyrot; Darlene Dreon; Vivien Zraick; Brett Cross; Meng H Tan
Journal:  Diabetes Ther       Date:  2018-01-11       Impact factor: 2.945

Review 5.  A review of the security of insulin pump infusion systems.

Authors:  Nathanael Paul; Tadayoshi Kohno; David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

6.  Lower rate of initial failures and reduced occurrence of adverse events with a new catheter model for continuous subcutaneous insulin infusion: prospective, two-period, observational, multicenter study.

Authors:  Eric Renard; Bruno Guerci; Anne-Marie Leguerrier; Robert Boizel
Journal:  Diabetes Technol Ther       Date:  2010-10       Impact factor: 6.118

Review 7.  Patch Pumps for Insulin.

Authors:  Barry H Ginsberg
Journal:  J Diabetes Sci Technol       Date:  2018-08-02

8.  Randomized Cross-Over Study Comparing Two Infusion Sets for CSII in Daily Life.

Authors:  Guido Freckmann; Stephan Arndt; Albrecht Fießelmann; Gerhard Klausmann; Kristina Pralle; Thomas Künsting; Bettina Petersen
Journal:  J Diabetes Sci Technol       Date:  2016-09-25

9.  Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial.

Authors:  Ralph Ziegler; David A Cavan; Iain Cranston; Katharine Barnard; Jacqueline Ryder; Claudia Vogel; Christopher G Parkin; Walter Koehler; Iris Vesper; Bettina Petersen; Matthias A Schweitzer; Robin S Wagner
Journal:  Diabetes Care       Date:  2013-07-30       Impact factor: 19.112

10.  Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.

Authors:  Bruce A Buckingham; Gregory P Forlenza; Jordan E Pinsker; Mark P Christiansen; R Paul Wadwa; Jennifer Schneider; Thomas A Peyser; Eyal Dassau; Joon Bok Lee; Jason O'Connor; Jennifer E Layne; Trang T Ly
Journal:  Diabetes Technol Ther       Date:  2018-02-12       Impact factor: 6.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.